Tag: Phaxiam
Phaxiam therapeutics (formerly erytech): Launch of a new preclinical program
Receive the value of the day for free every morning The data collected is essential for this processing and is intended for the relevant services of BFM Bourse and, where…
Phaxiam Therapeutics consolidated its shares – 09/18/2023 at 10:39
(AOF) – Phaxiam Therapeutics (formerly Erytech) announced today the completion of the consolidation of the shares making up its share capital as decided by the Chief Executive Officer on July…
Phaxiam Therapeutics has consolidated its shares
(AOF) – Phaxiam Therapeutics (formerly Erytech) announced today the completion of the consolidation of the shares making up its share capital as decided by the Chief Executive Officer on July…
Phaxiam: 25.2 million euros in cash at the end of June
(CercleFinance.com) – Phaxiam Therapeutics, the group resulting from the merger between Erytech and Pherecydes, reported on Wednesday a cash level of 25.2 million euros as of June 30. “The current…
Phaxiam Therapeutics (formerly Erytech): Akkadian Partners takes legal action – 07/04/2023 at 11:06
(AOF) – The activist fund Akkadian Partners, opposed to the merger between Erytech and Pherecydes (which gave birth to Phaxiam Therapeutics), indicates that it has kept all the shares it…
Erytech Pharma merges with Pherecydes and becomes Phaxiam Therapeutics – 06/26/2023 at 10:11
(AOF) – Erytech Pharma is up 1.23% to 0.82 euro after announcing that all the resolutions for which the Board of Directors recommended a favorable vote were adopted by its…